Table I.
Characteristics of patients.
| Characteristic | Number (n=114) | % |
|---|---|---|
| Median age, years (range) | 51 (30–75) | |
| PS | ||
| 0 | 47 | 41.2 |
| 1 | 51 | 44.7 |
| 2 | 13 | 11.4 |
| 3 | 3 | 2.6 |
| Histological diagnosis | ||
| Invasive lobular carcinoma | 21 | 19.6 |
| Invasive ductal carcinoma | 81 | 75.7 |
| Other | 5 | 4.7 |
| Missing | 7 | 6.1 |
| Initial stage | ||
| I–III | 95 | 83.3 |
| IV (de novo) | 19 | 16.7 |
| Hormone receptor status | ||
| ER+/PR+ | 94 | 82.5 |
| ER+/PR− | 19 | 16.6 |
| ER−/PR+ | 1 | 0.9 |
| Endocrine therapy | ||
| Fulvestrant | 97 | 85.1 |
| Letrozole | 17 | 14.9 |
| ALC, g/l | ||
| ≥1.50 | 49 | 43.0 |
| 1.49-0.80 | 47 | 41.0 |
| 0.79-0.50 | 13 | 12.0 |
| 0.49-0.20 | 5 | 4.0 |
PS, performance status; ER, estrogen receptor; PR, progesterone receptor; ALC, absolute lymphocyte count.